The global insufflation devices market size is expected to reach USD 4.26 billion by 2030, registering a CAGR of 6.4% during the forecast period, according to a new report by Grand View Research, Inc. Increasing adoption of minimally invasive surgeries, rapidly aging population, and rising number of laparoscopic procedures are among the major factors driving this market’s growth.
The COVID-19 outbreakhas caused the global implementation of strict measures to curbthe spread, which has led to the cancelation/delayof elective surgeries, including many laparoscopic procedures world wide. A large number of medical device manufacturing companies and global suppliers have been adversely affected during this time. However, with the abundance of deferred medical procedures in the pipeline, the market is likely to rebound and grow significantly over the forecast period.
Obesity or overweight are major health concerns that lead to a number of associated diseases or complications, such as diabetes and cardiovascular diseases. As per the WHO, in 2016, over 1.9 billion adults were overweight, out of which around 650 million people were obese and around 2.8 million people die each year as a result of being overweight/obese. Such instances are expected to increase the demand for bariatric procedures and other related surgeries, thereby propelling the market growth over the forecast period.
Moreover, growing patient preference for minimally invasive surgeries owing to the reduced risk and trauma associated with these procedures is expected to strengthen the growth of this market. Additionally, minimally invasive laparoscopic surgeries are increasingly being covered by health insurance providers in selected countries. For instance, for laparoscopic surgical operations, Medicare will cover up to 75% of the fee as listed in the Medicare Benefits Schedule. These factors have led to an increased preference for minimally invasive surgeries among patients.
Request a free sample copy or view report summary: Insufflation Devices Market Report
Insufflation Devices Market Report Highlights
Based on application, the laparoscopic surgery segment dominated the market with a share of more than 36.8% in 2023
North America dominated the market with a revenue share of over 37.7% in 2023 owing to the increasing number of laparoscopic procedures and technological advancements
In Asia Pacific, the market is anticipated to witness remarkable growth over the forecast period due to the presence of a large patient base suffering from chronic disorders and government initiatives for minimizing risks during the treatment.
Insufflation Devices Market Segmentation
Grand View Research has segmented the global insufflation devices market report based on application, end-use, and region:
Application Outlook (Revenue, USD Million, 2018 - 2030)
Laparoscopic Surgery
Bariatric Surgery
Cardiac Surgery
Other Surgeries
End Use Outlook (Revenue, USD Million, 2018 - 2030)
Ophthalmology
Microscopy
Laser Application
Manufacturing
Communications
Military & Defense
Others
Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Latin America
Brazil
Argentina
Middle East and Africa (MEA)
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in the Insufflation Devices Market
Fujifilm
Medtronic
Stryker
BD
Olympus
B. Braun Melsungen
Smith & Nephew
Karl Storz
Steris
CONMED
Richard Wolf
Explore Horizon, the world’s most expansive market research database
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.